Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- presença de fatores de risco
- ansiedade antecipatória e preocupação
- taquicardia
- hiperventilação
- sudorese
- rubor
- tensão muscular
Outros fatores diagnósticos
- processamento pós-evento
- vieses de atenção
- deficits de habilidades sociais
- choro, acessos de raiva ou "paralisia"
- mutismo seletivo
Fatores de risco
- comorbidade psiquiátrica (por exemplo, transtornos de ansiedade, humor e uso de substâncias)
- genética
- fatores de temperamento
- estilo de criação
- transtorno psicológico
- estressores da vida
- fatores ambientais
Investigações diagnósticas
Investigações a serem consideradas
- glicose sanguínea
- hormônio estimulante da tireoide sérico
- análise toxicológica (urina e sangue)
Algoritmo de tratamento
Colaboradores
Autores
Craig N. Sawchuk, PhD
Professor
Department of Psychiatry and Psychology
Mayo Clinic
Rochester
MN
Declarações
CNS declares that he has no competing interests.
Jason P. Veitengruber, MD
Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle
WA
Declarações
JPV is an author of a reference cited in this topic.
Bunmi O. Olatunji, PhD
Professor
Department of Psychological Sciences
Vanderbilt University
Nashville
TN
Declarações
BOO declares that he has no competing interests.
Stacy Shaw Welch, PhD
Director
Anxiety and Stress Reduction Center of Seattle
University of Washington
Seattle
WA
Declarações
SSW declares that she has no competing interests.
Revisores
Stefan G. Hofmann, PhD
Alexander von Humboldt Professor
Department of Psychology
Philipps University Marburg
Germany
Declarações
SGH is an author of a number of references cited in this topic.
Fallon R. Goodman, PhD
Assistant Professor of Psychology
George Washington University
Washington
DC
Declarações
FRG declares that she has no competing interests.
Richard P. Swinson, MD, FRCPC, FRCPsych
Emeritus Professor
Medical Director
Anxiety Treatment and Research Centre
McMaster University and St Joseph’s Hospital
Hamilton
Canada
Declarações
RPS declares that he has no competing interests.
David Baldwin, MD
Professor of Psychiatry
University of Southampton
Southampton
UK
Declarações
DB has acted as a consultant for and held research grants from Cephalon, Eli Lilly, GSK, Lundbeck, Organon, Pfizer, Pharmacia, Roche, and Wyeth and has also acted as a consultant to Asahi, AstraZeneca, Grunenthal, Pierre Fabre, Servier, Sumitomo, and Wyeth. He has accepted paid speaking engagements in industry-supported satellite symposia and is co-author of the BAP evidence-based guidelines on the treatment of anxiety disorders. He is also a Medical Patron of Anxiety UK.
O uso deste conteúdo está sujeito ao nosso aviso legal